Glucose Buddy Diabetes Tracker is a medical logging app for diabetes management, providing glucose, medication, and A1C tracking on iOS and Android.
The App DNA
What makes this app unique?
The app removes the cognitive friction of manual health logging by centralizing glucose, carb, and medication data into a single, shareable report for physician review.
For Individuals managing diabetes who require consistent blood sugar tracking, carb logging, and professional health guidance.
What does it look like?
Key features
Logs blood glucose levels with support for mg/dL and mmol/L units
Calculates long-term A1C trends based on logged glucose data
Syncs data from Dexcom and Agamatrix Jazz Wireless 2 meters
How much does it cost?
Freemium model gates advanced analytics and ad-free experience behind a monthly subscription, with additional revenue from hardware-service bundles.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app ships approximately 0.06 releases per week, placing it firmly in the maintenance tier. Development is characterized by infrequent, generic updates focused on performance and stability rather than new features or live operations. The latest release continues this trend of opaque maintenance, with no evidence of active feature development or seasonal content cycles over the last 12 months.
Who built it?
Azumio
9 apps tracked · Medical
Glucose Buddy+ for Diabetes
Instant Fitness: Workout Trainer
Calorie Mama AI: Diet Counter
Argus: Pedometer Step Tracker
Sleep Time+ Cycle Alarm Clock
Calorie Mama AI: Meal Planner 
Sleep Time: Cycle Alarm Clock
Argus: Activity & Step TrackerUser Sentiment
What do users think recently?
Fresh user feedback skews frustrated. Users appreciate long-term users value the comprehensive tracking of glucose, medication, and weight for medical reporting, but report persistent application crashes and loading failures following the latest update prevent users from accessing health data.
How are ratings & reviews evolving?
What users say, by theme
- Long-term users value the comprehensive tracking of glucose, medication, and weight for medical reporting
- Persistent application crashes and loading failures following the latest update prevent users from accessing health data
95 of 509 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Glucose Buddy Diabetes Tracker
How's the Medical market?
Glucose Buddy Diabetes Tracker sits #55 Grossing in the US Medical category, yet the 113-day gap since the last store update signals a shift toward maintenance-mode. The grossing rank lagging behind the app's 15-year legacy suggests that monetization pressure is currently outpacing feature value delivery.
Read the market outlookThe rivals identified
By Marwan Elwaraki
Both apps target diabetes management, but Sweet Dreams captures the family-coordination segment through shared subscriptions and real-time CGM hardware integration, directly challenging the individual-focused model of Glucose Buddy.
- Sweet Dreams offers family-bundled subscriptions, whereas Glucose Buddy relies on individual-only pricing tiers.
- Sweet Dreams provides Live Activity widgets for real-time monitoring, while Glucose Buddy lacks this hardware-integrated visibility.
- Sweet Dreams supports multi-device CGM hardware integration, a feature absent in the current Glucose Buddy build.
Glucose | Blood Sugar TrackerContender
Blood Pressure Tracker •Contender
Cuspart: Blood SugarContender
Glumio: Blood Sugar TrackerContender
Blood Pressure Log FeeltrackerContender
Diabetes Tracker by MyNetDiaryContenderUnlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Glucose Buddy Diabetes Tracker
Where is it heading?
The diabetes management market is consolidating around automated, CGM-integrated solutions that remove the manual logging friction Glucose Buddy requires. The current maintenance-mode cadence leaves the app exposed to churn, and the latest stability regressions will likely accelerate the loss of the legacy user base into Q3.
- The latest update introduced widespread launch failures, which erodes the daily active habit and compounds the rating drag already visible on Android.
- Maintenance-mode release cadence leaves the app exposed to live-ops rivals like mySugr, which iterate on features every two weeks.
The SWOT
- 15-year legacy builds trust for chronic condition management
- All-in-one dashboard reduces cognitive load for multi-metric tracking
- Implement offline-first data persistence to capture users in low-connectivity environments
Next best moves
Rebuild launch sequence because launch-time crashes are the #1 churn driver → restore daily active usage
+ 1 more prioritized moveThe counter-intuitive read
The app's 15-year legacy is currently a liability…
Read the full takeFeature gaps
Real-time CGM streaming (available in Libre by Abbott but absent here) +1
Since the last report: Launch-time stability failures have become the primary driver of user churn, shifting the app's sentiment from legacy trust to active dissatisfaction. This technical crisis is compounded by new reports of unresponsive billing support, further weakening the app's competitive standing.
Bottom line
Restoring core stability is the only path to retaining the legacy user base, as the current launch-time crashes are actively destroying the app's primary utility. Without a fix, the churn rate will continue to outpace new user acquisition.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated